What the Options Market Tells Us About Novo Nordisk
Portfolio Pulse from Benzinga Insights
Options market analysis for Novo Nordisk (NYSE:NVO) shows a bearish sentiment with 69% of trades being bearish. The price target range is between $95.0 and $145.0. Novo Nordisk, a leader in diabetes care, has seen its stock price increase by 2.56% to $122.84. Analysts have set an average target price of $140.0, with Cantor Fitzgerald analysts giving multiple Overweight ratings with a target of $140.
March 01, 2024 | 3:32 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Bearish options trading sentiment with a price target range of $95-$145. Stock price up 2.56% at $122.84. Analyst consensus target price at $140.
The bearish sentiment in the options market, despite a recent stock price increase, suggests mixed investor expectations. Analyst ratings, particularly the consistent target price of $140 by Cantor Fitzgerald, indicate a positive outlook. The relevance of this news to NVO is direct, impacting investor sentiment and potentially influencing short-term stock price movements.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100